The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review
Author(s)
Related Research Unit(s)
Detail(s)
Original language | English |
---|---|
Article number | 108488 |
Journal / Publication | Cell Reports |
Volume | 33 |
Issue number | 10 |
Online published | 18 Nov 2020 |
Publication status | Published - 8 Dec 2020 |
Link(s)
DOI | DOI |
---|---|
Attachment(s) | Documents
Publisher's Copyright Statement
|
Link to Scopus | https://www.scopus.com/record/display.uri?eid=2-s2.0-85097100224&origin=recordpage |
Permanent Link | https://scholars.cityu.edu.hk/en/publications/publication(5e584a3c-83dc-4fbc-ae6a-1e3a76719611).html |
Abstract
Trimpert et al. describe a highly susceptible non-transgenic rodent model for SARS-CoV-2 research. Roborovski hamsters develop fulminant clinical signs 2 to 4 days after infection. Comparison to closely related species reveals striking differences in disease susceptibility. This model mirrors severe human COVID-19 cases with great sensitivity for testing of vaccines and therapies.
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated an unprecedented and yet-unresolved health crisis worldwide. Different mammals are susceptible to SARS-CoV-2; however, few species examined so far develop robust clinical disease that mirrors severe human cases or allows testing of vaccines and drugs under conditions of severe disease. Here, we compare the susceptibilities of three dwarf hamster species (Phodopus spp.) to SARS-CoV-2 and introduce the Roborovski dwarf hamster (P. roborovskii) as a highly susceptible COVID-19 model with consistent and fulminant clinical signs. Particularly, only this species shows SARS-CoV-2-induced severe acute diffuse alveolar damage and hyaline microthrombi in the lungs, changes described in patients who succumbed to the infection but not reproduced in any experimentally infected animal. Based on our findings, we propose the Roborovski dwarf hamster as a valuable model to examine the efficacy and safety of vaccine candidates and therapeutics, particularly for use in highly susceptible individuals.
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated an unprecedented and yet-unresolved health crisis worldwide. Different mammals are susceptible to SARS-CoV-2; however, few species examined so far develop robust clinical disease that mirrors severe human cases or allows testing of vaccines and drugs under conditions of severe disease. Here, we compare the susceptibilities of three dwarf hamster species (Phodopus spp.) to SARS-CoV-2 and introduce the Roborovski dwarf hamster (P. roborovskii) as a highly susceptible COVID-19 model with consistent and fulminant clinical signs. Particularly, only this species shows SARS-CoV-2-induced severe acute diffuse alveolar damage and hyaline microthrombi in the lungs, changes described in patients who succumbed to the infection but not reproduced in any experimentally infected animal. Based on our findings, we propose the Roborovski dwarf hamster as a valuable model to examine the efficacy and safety of vaccine candidates and therapeutics, particularly for use in highly susceptible individuals.
Research Area(s)
- animal model, Campbell's dwarf hamster (Phodopus campbelli), coronavirus, COVID-19, Djungarian hamster (Phodopus sungorus), histopathology, pneumonia, Roborovski dwarf hamster (Phodopus roborovskii), thrombosis
Citation Format(s)
The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection. / Trimpert, Jakob; Vladimirova, Daria; Dietert, Kristina et al.
In: Cell Reports, Vol. 33, No. 10, 108488, 08.12.2020.
In: Cell Reports, Vol. 33, No. 10, 108488, 08.12.2020.
Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review
Download Statistics
No data available